Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South Africa

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Shittu, Adebayo O ^a,b   Lin, Johnson ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COAGULASE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; MINOCYCLINE; NEOMYCIN; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; PSEUDOMONIC ACID; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; CORRELATION ANALYSIS; HEALTH SURVEY; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTH AFRICA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; COAGULASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; METHICILLIN; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SOUTH AFRICA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33748707637     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-125     Document Type: Article

References (84)

1. Lowy FD: Staphylococcus aureus infection. N England J Med 1998, 339:520-532.
2. Boyce JM: Epidemiology and prevention of nosocomial infections. In The staphylococci in human disease Edited by: Crossley KB, Archer GL. Churchill Livingstone, New York; 1997:309-329.
3. Shopsin B, Kreiswirth BN: Molecular epidemiology of methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2001, 7:323-326.
4. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y: Comparison of mortality associated with methicillin resistant and methicillin sensitive Staphylococcus aureus bacteriemia: a meta analysis. Clin Infect Dis 2003, 36:53-59.
5. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS: Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003, 36:592-598.
6. American Society for Microbiology: New and Reemerging Infectious Diseases: A Global Crisis and Immediate Threat to the Nation's Health - The Role of Research. Publication of the American Society for Microbiology 1997:1.
7. Bouchillon SK, Johnson BM, Hoban DJ, Johnson JL, Dowzicky MJ, Wu DH, Visalli MA, Bradford PA: Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. Int J Antimicrob Agents 2004, 24:119-124.
8. Barber M, Rozwadowska-Dowzenko M: Infection by penicillin-resistant staphylococci. Lancet 1948, 1:641-644.
9. Jevons MP: Celbenin-resistant staphylococci. BMJ 1961, 1:124-125.
10. Duckworth G: Controlling methicillin-resistant Staphylococcus aureus. British Med Journal 2003, 327:1177-1178.
11. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA: Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Int Med 2002, 162:2229-2235.
12. Melzer M, Eykyn SJ, Gransden WR, Chinn S: Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 2003, 37:1453-1460.
13. Kopp BJ, Nix DE, Armstrong EP: Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Ann Pharmacother 2004, 38:1377-1382.
14. Cosgrove SE, Qi Y, Kaye KS, Harbath S, Karchmer AW, Carmeli Y: The impact of methicillin resistance in Staphylococcus aureus baceteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005, 26:166-174.
15. Lodise TP, McKinnon PS: Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 2005, 52:113-122.
16. Kim HB, Jang H-C, Nam HJ, Lee YS, Kim BS, Park WB, Lee KD, Choi YJ, Park SW, Oh MD, Kim E-C, Choe KW: In-vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey. Antimicrob Agents Chemother 2004, 48:1124-1127.
17. Scragg JN, Appelbaum PC, Govender DA: The spectrum of infection and sensitivity of organisms isolated from African and Indian children in a Durban hospital. Trans R Soc Trop Med Hyg 1978, 72:325-328.
18. Van den Ende J, Rotter ML: An analysis of blood culture isolates from 7 South African teaching hospital centres. S Afr Med J 1986, 69:89-93.
19. Peddie EF, Donald PR, Burger PJ, Sadler CA: Methicillin-resistant Staphylococcus aureus at Tygerberg Hospital. S Afr Med J 1988, 74:223-224.
20. Gardee Y, Kirby R: The incidence of inducible macrolide-lincosamide-streptogramin B resistance in methicillin-resistant staphylococci in clinical isolates from the Eastern Cape area of South Africa. Lett Appl Microbiol 1993, 17:264-268.
21. Ferraz V, Duse AG, Kassel M, Black AD, Ito T, Hiramatsu K: Vancomycin-resistant Staphylococcus aureus occurs in South Africa. S Afr Med J 2000, 90:1113.
22. Amod F, Moodley I, Peer AK, Sunderland J, Lovering A, Wootton M, Nadvi S, Vawda F: Ventriculitis due to a hetero strain of vancomycin intermediate Staphylococcus aureus (hVISA): successful treatment with linezolid in combination with intraventricular vancomycin. J Infect 2005, 50:252-257.
23. Murchan S, Kaufmann ME, Deplano A, de Ryck R, Struelens M, Zinn CE, Fussing V, Salmenlinna S, Vuopio-Varkila J, El Solh N, Cuny C, Witte W, Tassios PT, Legakis N, van Leeuwen W, van Belkum A, Vindel A, Laconcha I, Garaizar J, Coombs G, Cookson B: Harmonization of pulsed-field gel electrophoresis for epidemiological typing of methicillin-resistant Staphylococcus aureus by consensus in 10 European centers and its use to plot the spread of related strains. J Clin Microbiol 2003, 41:1574-1585.
24. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. NCCLS document M2-A8 2003, Wayne, PA-NCCLS.
25. Skov R, Frimodt-Moller N, Espersen F: Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid. Diagn Microbiol Infect Dis 2001, 40:111-116.
26. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH: Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003, 41:4740-4744.
27. Udo EE, Farook VS, Mokaddas EM, Jacob LE, Sanyal SC: Molecular fingerprinting of mupirocin-resistant methicillin-resistant Staphylococcus aureus from a Burns Unit. Int J Infect Dis 1999, 3:82-87.
28. Walsh TTR, Bolmstrom A, Qwarnstrom A, Ho P, Wootton M, Howe RA, MacGowan AP, Diekema D: Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 2001, 39:2439-2444.
29. Brakstad OG, Aasbakk K, Maeland JA: Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol 1992, 30:1654-1660.
30. Bignardi GE, Woodford N, Chapman A, Johnson AP, Speller DC: Detection of the mec-A gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillin resistance. J Antimicrob Chemother 1996, 37:53-63.
31. Woodford N, Watson AP, Patel S, Jevon M, Waghorn DJ, Cookson BD: Heterogeneous location of the mupA high-level resistance gene in Staphylococcus aureus. J Med Microbiol 1998, 47:829-835.
32. Shittu AO, Lin J, Kolawole DO: Antimicrobial susceptibility patterns of Staphylococcus aureus and characterization of MRSA in Southwestern Nigeria. WOUNDS 2006, 18:77-84.
33. Goh S-H, Byrne EE, Zhang JL, Chow AW: Molecular typing of Staphylococcus aureus on the basis of coagulase gene polymorphisms. J Clin Microbiol 1992, 30:1642-1645.
34. Annemuller C, Lammler Ch, Zschock M: Genotyping of Staphylococcus aureus isolated from bovine mastitis. Vet Microbiol 1999, 69:217-224.
35. Smolinski MS, Hamburg MA, Lederberg J, editors: Microbial threats to health: emergence, detection, and response. Washington: Institute of Medicine; 2003:32.
36. Hiramatsu K, Cui L, Kuroda M, Ito T: The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 2001, 9:486-493.
37. Tenover FC, Lancaster MV, Hill BC, Steward CD, Stocker SA, Hancock GA, O'Hara CM, McAllister SK, Clark NC, Hiramatsu K: Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopepticles. J Clin Microbiol 1998, 36:1020-1027.
38. Zinn CS, Westh H, Rosdahl VT, the SARISA Study Group: An international multicenter study of antimicrobial resistance and typing of hospital Staphylococcus aureus isolates from 21 laboratories in 19 countries or states. Microb Drug Resist 2004, 10:160-168.
39. Howden BP, Grayson ML: Dumb and Dumber - The potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus. Clin Infect Dis 2006, 42:394-400.
40. Van Belkum A, Verburgh H: 40 years of methicillin resistant Staphylococcus aureus. BMJ 2001, 323:644-645.
41. National Nosocomial Infections Surveillance (NNIS) System Report: Data summary from January 1992 through June issued August 2003. American Journal of Infection Control 2003, 31:481-498.
42. Subedi S, Brahmadathan KN: Antimicrobial susceptibility patterns of clinical isolates of Staphylococcus aureus in Nepal. Clin Microbiol Infect 2005, 11:235-237.
43. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M, the SENTRY Participants Group: Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001, 32(Suppl 2):S114-S132.
44. Bell JM, Turnidge JD, SENTRY APAC Participants: High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: Results from SENTRY Antimicrobial Surveillance Program, 1998-1999. Antimicrob Agents Chemother 2002, 46:879-881.
45. Christiansen KJ, Bell JM, Turnidge JD, Jones RN: Antimicrobial activities of Garenoxacin (BMS 284756) against Asia-Pacific Region Clinical Isolates from the SENTRY Program, 1999 to 2001. Antimicrob Agents Chemother 2004, 48:2049-2055.
46. Fluit AC, Wielders CLC, Verhoef J, Schmitz FJ: Epidemiology and Susceptibility of 3,051 Staphylococcus aureus isolates from 25 University Hospitals participating in the European SENTRY study. J Clin Microbiol 2001, 39:3727-3732.
47. Schmitz FJ, Fluit AC, Gondolf M, Beyrau R, Lindenlauf E, Verhoef J, Heinz H-P, Jones ME: The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci in 19 European hospitals. J Antimicrob Chemother 1999, 43:253-259.
48. Hanssen AM, Ericson Sollid JU: SCC mec in staphylococci: genes on the move. FEMS Immunol Med Microbiol 2006, 46:8-20.
49. Kuroda M, Ohta T, Uchiyama I, 34 other authors: Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet 2001, 357:1225-1240.
50. Kesah C, Redjeb SB, Odugbemi TO, Boye CS-B, Dosso M, Ndinya Achola JO, Koulla-Shiro S, Benbachir M, Rahal K, Borg M: Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta. Clin Microbiol Infect 2003, 9:153-156.
51. Schmitz FJ, Krey A, Giesel P, Verhoef J, Heinz HP, Fluit AC: Susceptibility of 302 methicillin-resistant Staphylococcus aureus isolates from 20 European university hospitals to vancomycin and alternative antistaphylococcal compounds. Eur J Clin Microbiol Infect Dis 1999, 18:528-530.
52. Santos Sanches IS, Mato R, de Lencastre H, Tomasz A, CEM/NET Collaborators, the International Collaborators: Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international muticenter study RESIST in 1997 and 1998. Microb Drug Resist 2000, 6:199-211.
53. Levin TP, Suh B, Axelrod P, Truant AL, Fekete T: Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrob Agents Chemother 2005, 49:1222-1224.
54. Denis O, Deplano A, Nonhoff C, De Ryck R, de Mendonca R, Rottiers S, Vanhoof R, Struelens MJ: National surveillance of methicillin-resistant Staphylococcus aureus in Belgian hospitals indicates rapid diversification of epidemic clones. Antimicrob Agents Chemother 48:3625-3629.
55. Fokas S, Fokas S, Tsironi M, Kalkani M, Dionysopouloy M: Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp. Clin Microbiol Infect 2005, 11:337-340.
56. National Committee for Clinical Laboratory Standards (now CLSI): Performance standards for antimicrobial disk susceptibility tests. 12th informational document NCCLS document M100-S14 2004, PA-NCCLS.
57. Gottlieb T, Mitchell D: The independent evolution of resistance to ciprofloxacin, rifampicin and fusidic acid in methicillin resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995) Australian Group for Antimicrobial Resistance (AGAR). J Antimicrob Chemother 1998, 42:67-73.
58. Aucken HM, Ganner M, Murchan S, Cookson BD, Johnson AP: A new UK strain of epidemic methicillin resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics. J Antimicrob Chemother 2002, 50:171-175.
59. Norazah A, Lim VKE, Koh YT, Rohani MY, Zuridah H, Spencer K, Ng PP, Kamel AGM: Molecular fingerprinting of fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals. J Med Microbiol 2002, 51:1113-1116.
60. Tosun I, Udo EE, Noronha B, Caylan R, Aydin F, Yetiskul S, Koksal I: Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus isolated at a Turkish hospital. Microb Drug Resist 2005, 11:48-52.
61. Matynia B, Mtodzinska E, Hryniewicz W: Antimicrobial susceptibility patterns of Staphylococcus aureus in Poland obtained by the National Quality Assurance Programme. Clin Microbiol Infect 2005, 11:379-385.
62. Lin J, Satter AN, Puckree T: An alarming rate of drug-resistant tuberculosis at Ngwelezane Hospial in Northern KZN, South Africa. Int J Tuberc Lung Dis 2004, 8:568-573.
63. Lin J, Biyela PT, Puckree T: Antibiotic resistance profiles of environmental isolates from Mhlathuze River, KwaZulu-Natal (RSA). Water SA 2004, 30:23-28.
64. Rayner C, Munckhof WJ: Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus. Int Med J 2005, 35:S3-S16.
65. Brumfitt W, Hamilton-Miller J: Methicillin-resistant Staphylococcus aureus. N Engl J Med 1989, 320:1188-1196.
66. Maple PAC, Hamilton-Miller JMT, Brumfitt W: World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet 1989, 1:537-539.
67. Shanson DC: Clinical relevance of resistance to fusidic acid in Staphylococcus aureus. J Antimicrob Chemother 1990, 25(Suppl B):15-21.
68. Turnidge J, Grayston ML: Optimum treatment of staphylococcal infections. Drugs 1993, 45:353-366.
69. Johnson JR: Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections (letter). Clin Infect Dis 2003, 36:236-237.
70. Maniatis N, Agel A, Legakis NJ, Tzouveliekis LS: Mupirocin resistance in Staphylococcus aureus in Greece. Int J Antimicrob Agents 2001, 18:407-408.
71. Petinaki E, Spiliopoulou I, Kontos F, Maniati M, Bersos Z, Stakias N, Malamou-Lada H, Koutsia-Carouzou Ch, Maniatis AN: Clonal dissemination of mupirocin-resistant staphylococci in Greek hospitals. J Antimicrob Chemother 2004, 53:105-108.
72. Yun H-J, Lee SW, Yoon GM, Kim SY, Choi S, Lee SY, Choi E-C, Kim S: Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital. J Antimicrob Chemother 2003, 51:619-623.
73. Leski TA, Gniadkowski M, Skoczynska A, Stefaniuk E, Trzcinski K, Hryniewicz W: Outbreak of mupirocin-resistant staphylococci in a hospital in Warsaw, Poland, due to plasmid transmission and clonal spread of several strains. J Clin Microbiol 1999, 37:2781-2788.
74. AL. In Bergey's Manual of Systematic Bacteriology Volume 2. Edited by: Sneath PHA, Mair NS, Sharpe ME, Holt JG. Williams & Wilkins Baltimore, Md; 1986:1013-1035.
75. Carter PE, Begbie K, Thomson-Carter FM: Coagulase gene variants associated with distinct populations of Staphylococcus aureus. Epidemiol Infect 2003, 130:207-219.
76. Hookey JV, Richardson JF, Cookson BD: Molecular typing of Staphylococcus aureus based on PCR restriction fragment length polymorphism and DNA sequence analysis of the coagulase gene. J Clin Microbiol 1998, 36:1083-1089.
77. Schwarzkopf A, Karch H: Genetic variation in Staphylococcus aureus coagulase genes: potential and limits for use as an epidemiological marker. J Clin Microbiol 1994, 32:2407-2412.
78. Kobayashi N, Tanguchi K, Kojima K, Urasawa S, Uehara N, Omizu A, Yagihashi A, Kurokawa I: Analysis of methicillin-resistant and methicillin-susceptible Staphylococcus aureus by a molecular typing method based on coagulase gene polymorphism. Epidemiol Infect 1995, 115:419-426.
79. Lawrence C, Cosseron M, Mimoz O, Brun-Buisson C, Costa Y, Sammii K, Duval J, Leclercq R: Use of the coagulase gene typing method for the detection of carriers of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1996, 37:687-696.
80. Nada T, Ichiyama S, Osada Y, Ohta M, Shimokata K, Kato N, Nakashima N: Comparison of DNA fingerprints by PFGE and PCR-RFLP of the coagulase gene to distinguish MRSA isolates. J Hosp Infect 1996, 32:305-317.
81. Hoefnagels-Schuermans A, Peetermans WE, Struelens MJ, van Lierde S, van Eldere J: Clonal analysis and identification of epidemic strains of methicillin-resistant Staphylococcus aureus by anti-biotyping and determination of protein A gene and coagulase gene polymorphisms. J Clin Microbiol 1997, 35:2514-2520.
82. Wichelhaus TA, Hunfeld K-P, Boddinghaus B, Kraiczy P, Schafer V, Brade V: Rapid molecular typing of methicillin-resistant Staphylococcus aureus by PCR-RFLP. Infection Control and Hospital Epidemiology 2001, 22:294-298.
83. Montesinos I, Salido E, Delgado T, Cuervo M, Sierra A: Epidemiologic genotyping of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis at a University hospital and comparison with antibiotyping and protein A and coagulase gene polymorphisms. J Clin Microbiol 2002, 40:2119-2125.
84. Hookey JV, Edwards V, Cookson BD, Richardson JF: PCR-RFLP analysis of the coagulase gene of Staphylococcus aureus: application to the differentiation of epidemic and sporadic methicillin-resistant strains. J Hosp Infect 1999, 42:205-212.